ALCOR Stock Overview
Biocorp Production designs, develops, and manufactures medical devices in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ALCOR from our risk checks.
Biocorp Production Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €35.10 |
| 52 Week High | €35.10 |
| 52 Week Low | €13.55 |
| Beta | 0.96 |
| 11 Month Change | 0% |
| 3 Month Change | 2.63% |
| 1 Year Change | 150.71% |
| 33 Year Change | 6.36% |
| 5 Year Change | 317.86% |
| Change since IPO | 286.56% |
Recent News & Updates
Recent updates
Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?
Dec 08
What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates
Jun 26Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates
Apr 11What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?
Mar 04Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?
Jan 10
What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?
Nov 18Shareholder Returns
| ALCOR | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -0.04% |
| 1Y | 150.7% | 25.2% | -3.4% |
Return vs Industry: ALCOR exceeded the French Medical Equipment industry which returned 0.6% over the past year.
Return vs Market: ALCOR exceeded the French Market which returned 10.3% over the past year.
Price Volatility
| ALCOR volatility | |
|---|---|
| ALCOR Average Weekly Movement | 0.6% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in FR Market | 9.6% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALCOR has not had significant price volatility in the past 3 months.
Volatility Over Time: ALCOR's weekly volatility has decreased from 7% to 1% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 75 | Eric Dessertenne | biocorpsys.com |
Biocorp Production designs, develops, and manufactures medical devices in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; Sween, a device that provides real assistance in the administration of medication and closure systems.
Biocorp Production Fundamentals Summary
| ALCOR fundamental statistics | |
|---|---|
| Market cap | €154.53m |
| Earnings (TTM) | -€2.14m |
| Revenue (TTM) | €12.80m |
12.1x
P/S Ratio-72.3x
P/E RatioIs ALCOR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALCOR income statement (TTM) | |
|---|---|
| Revenue | €12.80m |
| Cost of Revenue | €5.24m |
| Gross Profit | €7.56m |
| Other Expenses | €9.70m |
| Earnings | -€2.14m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.49 |
| Gross Margin | 59.05% |
| Net Profit Margin | -16.68% |
| Debt/Equity Ratio | 234.8% |
How did ALCOR perform over the long term?
See historical performance and comparison